Project Grant G08LM014413
Award Date
9/9/24
Completion Date
7/31/27
Dollars Obligated
$147K
Federal Agency
National Institute of Environmental Health Sciences
Federal Grant Program
93.879
Assistance Type
Project Grant
Place of Performance
Charleston, SC 29425, USA
Similar Awards
This $334,233 federal Project Grant awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports a research project conducted by the University of South Carolina to examine disparities in cancer care and outcomes. The project aims to: Describe and compare patterns of novel targeted therapies for lung and colon cancer by race, socioeconomic status, and urban/rural designation, and their impact on survival disparities. Describe and...
This $432,304 federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), supports a research project titled "Enhanced Cancer Risk Predictions in Underrepresented Populations through Robust Multi-Source Data Integration." The project aims to develop novel data integration methods to enhance cancer risk prediction models, particularly for Black and Hispanic populations who face disproportionate cancer...
This federal Project Grant award, with funding of $892,112 from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research), aims to optimize and validate the Veris Health Cancer Care Platform for the needs of medically underserved cancer patients receiving outpatient chemotherapy. The study will focus on enhancing the platform's accessibility and cultural/linguistic appropriateness for patients with language barriers, limited...
This is a Project Grant award of $629,179 from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), to the Medical University of South Carolina (MUSC). The project aims to characterize the impact of aging and multi-morbidity on treatment outcomes, quality of life, and patient preferences for oropharyngeal cancer (OPC) patients, particularly older adults. The research will leverage large patient data sources to develop and validate a...
This federal Project Grant award, funded by the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), aims to investigate the biological mechanisms underlying racial disparities in head and neck cancer outcomes, particularly among Black patients. The $714,062 award, with a period of performance from April 2025 to March 2030, will be provided to the University of California, San Francisco (UCSF) to pursue two key objectives: 1) Developing a tailored RNA...
This $2,372,456 federal Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports a multi-institutional research collaboration led by Memorial Sloan Kettering Cancer Center to leverage observational (real-world) data to advance precision oncology. The key products/services to be delivered include: Overcoming methodological barriers in analyzing observational clinico-genomic data (Project 1) Addressing the role of...
This federal Project Grant award, funded by the National Cancer Institute under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353), will support a $1,165,096 research project to investigate the social genomic mechanisms linking structural racism, perceived discrimination, and breast cancer survival. The primary awardee, Sloan-Kettering Institute for Cancer Research, will lead a collaborative effort to define the contributions of objective structural...
The National Cancer Institute (NCI) awarded a $621,732 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The Medical University of South Carolina (MUSC) to evaluate a proactive identification and digital mental health intervention approach to address unmet psychosocial needs of individuals living with likely incurable cancer. The project aims to: 1) comprehensively assess the effectiveness of a proactive identification and digital mental health intervention...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $627,833 to The University of Texas Southwestern Medical Center (UT Southwestern) to develop an informatics platform that integrates molecular and histopathological data from various lung cancer preclinical models and patient tumors. The goal is to assess the fidelity of these preclinical models to human lung cancer. Key products and services to be delivered include: Harmonizing...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) in the amount of $368,070 will fund research to identify and address barriers in the cervical cancer treatment cascade among women with HIV in South Africa. The award, with a period of performance from July 1, 2024 to June 30, 2026, will support a multi-level intervention tailored to the unique needs of this population. The key products and services to be delivered under...